The increased CCL2 is secreted into the tumor microenvironment, promoting the recruitment of tumor associated macrophages (TAM), and then promoting lymphatic metastasis through the secretion of vascular endothelial growth factor C (VEGF-C) [86]. The gene discussed is VEGFC; the disease is neoplasm.